Trinity Biotech plc (TRIB) Earnings History
Net Loss33 years of earnings data (1993–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
Trinity Biotech plc (TRIB) Earnings Overview
As of June 30, 2026, Trinity Biotech plc (TRIB) reported trailing twelve-month net income of -$37M, reflecting -13.0% year-over-year growth. The company earned $-2.01 per diluted share over the past four quarters, with a net profit margin of -85.4%.
Looking at the long-term picture, TRIB's historical earnings data spans multiple years. The company achieved its highest annual net income of $60M in fiscal 2010.
Trinity Biotech plc is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including OSUR (-$53M net income, -59.8% margin), CHEK (-$25M net income), LMAT ($62M net income, 23.1% margin), TRIB has room to improve margins relative to the peer group. Compare TRIB vs OSUR →
TRIB Earnings vs Peers
Earnings metrics vs comparable public companies
TRIB Historical Earnings Data (1993–2025)
33 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$37M | -17.6% | -$11M | $-2.00 | -85.4% | -26.1% |
| 2024 | -$32M | -32.4% | -$21M | $-1.77 | -51.6% | -34.4% |
| 2023 | -$24M | +41.4% | -$27M | $-3.20 | -42.3% | -47.6% |
| 2022 | -$41M | -4785.9% | -$15M | $-5.20 | -65.6% | -24.4% |
| 2021 | $875,000 | +113.7% | $4M | $0.16 | 1.1% | 4.9% |
| 2020 | -$6M | -57.1% | $82,000 | $-1.54 | -6.3% | 0.1% |
| 2019 | -$4M | -270.1% | $872,000 | $-0.80 | -4.5% | 1.0% |
| 2018 | $2M | +105.9% | $3M | $0.46 | 2.5% | 3.4% |
| 2017 | -$40M | +60.0% | $5M | $-7.49 | -40.6% | 5.5% |
| 2016 | -$101M | -561.7% | $7M | $-17.78 | -101.0% | 7.5% |
| 2015 | $22M | +26.6% | $13M | $0.48 | 21.8% | 13.4% |
| 2014 | $17M | +66.5% | $18M | $0.73 | 16.4% | 17.2% |
| 2013 | $10M | -40.4% | $18M | $0.41 | 11.3% | 19.6% |
| 2012 | $17M | +11.2% | $17M | $0.77 | 21.0% | 20.8% |
| 2011 | $16M | -74.2% | $16M | $0.70 | 20.0% | 20.2% |
| 2010 | $60M | +411.0% | $14M | $2.79 | 67.4% | 15.7% |
| 2009 | $12M | +115.2% | $14M | $2.26 | 9.4% | 11.2% |
| 2008 | -$78M | -119.9% | -$80M | $-19.11 | -55.5% | -56.8% |
| 2007 | -$35M | -1179.7% | -$29M | $-9.30 | -24.6% | -20.5% |
| 2006 | $3M | -38.0% | $2M | $0.20 | 2.8% | 1.6% |
| 2005 | $5M | +2.2% | $7M | $0.36 | 5.4% | 6.7% |
| 2004 | $5M | -10.9% | $6M | $1.44 | 6.5% | 7.2% |
| 2003 | $6M | +15.7% | $10M | $1.92 | 8.8% | 14.7% |
| 2002 | $5M | +245.7% | $6M | $1.92 | 9.6% | 12.4% |
| 2001 | $1M | -70.0% | $2M | $0.56 | 3.9% | 5.9% |
| 2000 | $5M | -1.9% | $7M | $1.95 | 16.2% | 21.9% |
| 1999 | $5M | +89.1% | $5M | $2.20 | 18.8% | 19.8% |
| 1998 | $3M | +116.7% | $3M | $1.17 | 11.2% | 12.5% |
| 1997 | $1M | +233.3% | $500,000 | $0.54 | 7.1% | 3.0% |
| 1996 | $-900,000 | -12.5% | $-700,000 | $-0.40 | -12.5% | -9.7% |
| 1995 | $-800,000 | +75.8% | -$2M | $-0.36 | -8.1% | -18.2% |
| 1994 | -$3M | +2.9% | -$3M | $-1.32 | -63.5% | -51.9% |
| 1993 | -$3M | - | -$4M | $-2.39 | -141.7% | -175.0% |
Download Data
Export TRIB earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
33+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
TRIB — Frequently Asked Questions
Quick answers to the most common questions about buying TRIB stock.
What is TRIB earnings per share (EPS)?
TRIB trailing twelve-month (TTM) diluted EPS is $-2.01, reflecting -13.0% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 1993 to 2025 is available in the table on this page.
What is Trinity Biotech plc's net income?
Trinity Biotech plc (TRIB) trailing twelve-month net income is $-37M as of 2025. Earnings declined -13.0% year-over-year.
Is TRIB profitable?
TRIB is not currently profitable on a TTM basis, reporting a net loss of $-37M. Net margin is -85.4%. Investors should monitor for a return to profitability.
What is TRIB's earnings growth rate?
TRIB compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 1993 to 2025.
What are TRIB's profit margins?
Trinity Biotech plc net profit margin is -85.4%, operating margin is -26.1%, and gross margin is +38.6%. Below-average margins reflect competitive or cost pressures. Return on Equity is N/A.
Is TRIB growing earnings?
TRIB earnings are declining — EPS fell -13.0% year-over-year. TTM net income dropped to $-37M. This contrasts with the 5-year CAGR of N/A.
What was TRIB's best earnings year?
Trinity Biotech plc's highest annual net income on record is $60M, achieved in fiscal year 2010. Earnings history on this page spans 1993 to 2025 and includes all annual and quarterly figures.
What were TRIB's earnings last quarter?
TRIB's most recent reported quarter was Q4 2025. Net income was $-17M with diluted EPS of $-0.94. For a full breakdown of all quarters, see the quarterly earnings table on this page.